| 前收盘价格 | 8.29 |
| 成交量 | 106,695 |
| 预期市盈率 (P/E Forward) | 15.43 |
| 价格/销量 (P/S) | 2.51 |
| 股市价格/股市净资产 (P/B) | 1.77 |
| 52周波幅 | |
| 股息率 (DY TTM) | 5.12% |
| 营业毛利率 | 9.60% |
| 营业利益率 (TTM) | 17.71% |
| 稀释每股收益 (EPS TTM) | 0.280 |
| 季度收入增长率 (YOY) | 16.60% |
| 季度盈利增长率 (YOY) | 67.60% |
| 总债务/股东权益 (D/E MRQ) | 4.41% |
| 流动比率 (MRQ) | 3.30 |
| 营业现金流 (OCF TTM) | 46.06 M |
| 杠杆自由现金流 (LFCF TTM) | 36.83 M |
| 资产报酬率 (ROA TTM) | 4.14% |
| 股东权益报酬率 (ROE TTM) | 6.44% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 看涨 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 看涨 | |
| 股票 | Kamada Ltd. | 混合的 | 看跌 |
AIStockmoo 评分
1.8
| 分析师共识 | NA |
| 内部交易活动 | -1.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.78 |
|
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Growth |
| 内部持股比例 | 7.22% |
| 机构持股比例 | 48.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Phoenix Financial Ltd. | 30 Jun 2026 | 1,654,952 |
| Ark Investment Management Llc | 30 Jun 2026 | 263,304 |
| Huntleigh Advisors, Inc. | 30 Jun 2026 | 162,644 |
| Renaissance Group Llc | 30 Jun 2026 | 124,896 |
| Man Group Plc | 30 Jun 2026 | 61,889 |
| Envestnet Asset Management Inc | 30 Jun 2026 | 54,669 |
| Lsv Asset Management | 30 Jun 2026 | 47,800 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BRENNER YAEL | - | 8.40 | -865 | -7,266 |
| TSUR DAVID | - | 8.40 | -9,166 | -76,994 |
| 累积净数量 | -10,031 | |||
| 累积净值 ($) | -84,260 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 8.40 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BRENNER YAEL | 职员 | 02 Sep 2026 | 处理 (-) | 865 | 8.40 | 7,266 |
| BRENNER YAEL | 职员 | 02 Sep 2026 | 执行期权 | 3,036 | - | - |
| TSUR DAVID | 董事 | 02 Sep 2026 | 处理 (-) | 9,166 | 8.40 | 76,994 |
| TSUR DAVID | 董事 | 02 Sep 2026 | 执行期权 | 49,000 | - | - |
| 股息率 (DY TTM) | 5.12% |
| 1年平均股息收益率 | 2.83% |
| 预计下次股息支付 | Apr 2027 |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 27 Aug 2026 | 17 Aug 2026 | 17 Sep 2026 | 0.17 现金 |
| 23 Mar 2026 | 11 Mar 2026 | 07 Apr 2026 | 0.25 现金 |
| 17 Mar 2025 | 05 Mar 2025 | 07 Apr 2025 | 0.2 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2026 | 0.420 | 2 | 5.12 |
| 2025 | 0.200 | 1 | 2.83 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合